Preoperative Prediction Model for Early Recurrence of Intrahepatic Cholangiocarcinoma after Surgical Resection: Development and External Validation Study
Purpose We aimed to develop a preoperative risk scoring system to predict early recurrence (ER) of intrahepatic cholangiocarcinoma (ICCA) after resection, utilizing clinical and computed tomography (CT) features.Materials and Methods This multicenter study included 365 patients who underwent curativ...
Saved in:
| Published in | Cancer research and treatment Vol. 57; no. 4; pp. 1156 - 1166 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Korea (South)
대한암학회
01.10.2025
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1598-2998 2005-9256 2005-9256 |
| DOI | 10.4143/crt.2024.1187 |
Cover
| Abstract | Purpose We aimed to develop a preoperative risk scoring system to predict early recurrence (ER) of intrahepatic cholangiocarcinoma (ICCA) after resection, utilizing clinical and computed tomography (CT) features.Materials and Methods This multicenter study included 365 patients who underwent curative-intent surgical resection for ICCA at six institutions between 2009 and 2016. Of these, 264 patients from one institution constituted the development cohort, while 101 patients from the other institutions constituted the external validation cohort. Logistic regression models were constructed to predict ER based on preoperative variables and were subsequently translated into a risk scoring system. The discrimination performance of the risk scoring system was validated using external data and compared to the American Joint Committee on Cancer (AJCC) TNM staging system.Results Among the 365 patients (mean age, 62±10 years), 153 had ER. A preoperative risk scoring system that incorporated both clinical and CT features demonstrated superior discriminatory performance compared to the postoperative AJCC TNM staging system in both the development (area under the curve [AUC], 0.78 vs. 0.68; p=0.002) and validation cohorts (AUC, 0.69 vs. 0.66; p=0.641). The preoperative risk scoring system effectively stratified patients based on their risk for ER: the 1-year recurrence-free survival rates for the low, intermediate, and high-risk groups were 85.5%, 56.6%, and 15.6%, respectively (p < 0.001) in the development cohort, and 87.5%, 58.5%, and 25.0%, respectively (p < 0.001) in the validation cohort.Conclusion A preoperative risk scoring system that incorporates clinical and CT imaging features was valuable in identifying high-risk patients with ICCA for ER following resection. |
|---|---|
| AbstractList | We aimed to develop a preoperative risk scoring system to predict early recurrence (ER) of intrahepatic cholangiocarcinoma (ICCA) after resection, utilizing clinical and computed tomography (CT) features.PurposeWe aimed to develop a preoperative risk scoring system to predict early recurrence (ER) of intrahepatic cholangiocarcinoma (ICCA) after resection, utilizing clinical and computed tomography (CT) features.This multicenter study included 365 patients who underwent curative-intent surgical resection for ICCA at six institutions between 2009 and 2016. Of these, 264 patients from one institution constituted the development cohort, while 101 patients from the other institutions constituted the external validation cohort. Logistic regression models were constructed to predict ER based on preoperative variables and were subsequently translated into a risk-scoring system. The discrimination performance of the risk-scoring system was validated using external data and compared to the American Joint Committee on Cancer (AJCC) TNM staging system.Materials and MethodsThis multicenter study included 365 patients who underwent curative-intent surgical resection for ICCA at six institutions between 2009 and 2016. Of these, 264 patients from one institution constituted the development cohort, while 101 patients from the other institutions constituted the external validation cohort. Logistic regression models were constructed to predict ER based on preoperative variables and were subsequently translated into a risk-scoring system. The discrimination performance of the risk-scoring system was validated using external data and compared to the American Joint Committee on Cancer (AJCC) TNM staging system.Among the 365 patients (mean age, 62±10 years), 153 had ER. A preoperative risk scoring system that incorporated both clinical and CT features demonstrated superior discriminatory performance compared to the postoperative AJCC TNM staging system in both the development (area under the curve [AUC], 0.78 vs. 0.68; p=0.002) and validation cohorts (AUC, 0.69 vs. 0.66; p=0.641). The preoperative risk scoring system effectively stratified patients based on their risk for ER: the 1-year recurrence-free survival rates for the low, intermediate, and high-risk groups were 85.5%, 56.6%, and 15.6%, respectively (p<0.001) in the development cohort, and 87.5%, 58.5%, and 25.0%, respectively (p<0.001) in the validation cohort.ResultsAmong the 365 patients (mean age, 62±10 years), 153 had ER. A preoperative risk scoring system that incorporated both clinical and CT features demonstrated superior discriminatory performance compared to the postoperative AJCC TNM staging system in both the development (area under the curve [AUC], 0.78 vs. 0.68; p=0.002) and validation cohorts (AUC, 0.69 vs. 0.66; p=0.641). The preoperative risk scoring system effectively stratified patients based on their risk for ER: the 1-year recurrence-free survival rates for the low, intermediate, and high-risk groups were 85.5%, 56.6%, and 15.6%, respectively (p<0.001) in the development cohort, and 87.5%, 58.5%, and 25.0%, respectively (p<0.001) in the validation cohort.A preoperative risk scoring system that incorporates clinical and CT imaging features was valuable in identifying high-risk patients with ICCA for ER following resection.ConclusionA preoperative risk scoring system that incorporates clinical and CT imaging features was valuable in identifying high-risk patients with ICCA for ER following resection. We aimed to develop a preoperative risk scoring system to predict early recurrence (ER) of intrahepatic cholangiocarcinoma (ICCA) after resection, utilizing clinical and computed tomography (CT) features. This multicenter study included 365 patients who underwent curative-intent surgical resection for ICCA at six institutions between 2009 and 2016. Of these, 264 patients from one institution constituted the development cohort, while 101 patients from the other institutions constituted the external validation cohort. Logistic regression models were constructed to predict ER based on preoperative variables and were subsequently translated into a risk scoring system. The discrimination performance of the risk scoring system was validated using external data and compared to the American Joint Committee on Cancer (AJCC) TNM staging system. Among the 365 patients (mean age, 62±10 years), 153 had ER. A preoperative risk scoring system that incorporated both clinical and CT features demonstrated superior discriminatory performance compared to the postoperative AJCC TNM staging system in both the development (area under the curve [AUC], 0.78 vs. 0.68; p=0.002) and validation cohorts (AUC, 0.69 vs. 0.66; p=0.641). The preoperative risk scoring system effectively stratified patients based on their risk for ER: the 1-year recurrence-free survival rates for the low, intermediate, and high-risk groups were 85.5%, 56.6%, and 15.6%, respectively (p < 0.001) in the development cohort, and 87.5%, 58.5%, and 25.0%, respectively (p < 0.001) in the validation cohort. A preoperative risk scoring system that incorporates clinical and CT imaging features was valuable in identifying high-risk patients with ICCA for ER following resection. Purpose We aimed to develop a preoperative risk scoring system to predict early recurrence (ER) of intrahepatic cholangiocarcinoma (ICCA) after resection, utilizing clinical and computed tomography (CT) features.Materials and Methods This multicenter study included 365 patients who underwent curative-intent surgical resection for ICCA at six institutions between 2009 and 2016. Of these, 264 patients from one institution constituted the development cohort, while 101 patients from the other institutions constituted the external validation cohort. Logistic regression models were constructed to predict ER based on preoperative variables and were subsequently translated into a risk scoring system. The discrimination performance of the risk scoring system was validated using external data and compared to the American Joint Committee on Cancer (AJCC) TNM staging system.Results Among the 365 patients (mean age, 62±10 years), 153 had ER. A preoperative risk scoring system that incorporated both clinical and CT features demonstrated superior discriminatory performance compared to the postoperative AJCC TNM staging system in both the development (area under the curve [AUC], 0.78 vs. 0.68; p=0.002) and validation cohorts (AUC, 0.69 vs. 0.66; p=0.641). The preoperative risk scoring system effectively stratified patients based on their risk for ER: the 1-year recurrence-free survival rates for the low, intermediate, and high-risk groups were 85.5%, 56.6%, and 15.6%, respectively (p < 0.001) in the development cohort, and 87.5%, 58.5%, and 25.0%, respectively (p < 0.001) in the validation cohort.Conclusion A preoperative risk scoring system that incorporates clinical and CT imaging features was valuable in identifying high-risk patients with ICCA for ER following resection. Purpose We aimed to develop a preoperative risk scoring system to predict early recurrence (ER) of intrahepatic cholangiocarcinoma (ICCA) after resection, utilizing clinical and computed tomography (CT) features.Materials and Methods This multicenter study included 365 patients who underwent curative-intent surgical resection for ICCA at six institutions between 2009 and 2016. Of these, 264 patients from one institution constituted the development cohort, while 101 patients from the other institutions constituted the external validation cohort. Logistic regression models were constructed to predict ER based on preoperative variables and were subsequently translated into a risk scoring system. The discrimination performance of the risk scoring system was validated using external data and compared to the American Joint Committee on Cancer (AJCC) TNM staging system.Results Among the 365 patients (mean age, 62±10 years), 153 had ER. A preoperative risk scoring system that incorporated both clinical and CT features demonstrated superior discriminatory performance compared to the postoperative AJCC TNM staging system in both the development (area under the curve [AUC], 0.78 vs. 0.68; p=0.002) and validation cohorts (AUC, 0.69 vs. 0.66; p=0.641). The preoperative risk scoring system effectively stratified patients based on their risk for ER: the 1-year recurrence-free survival rates for the low, intermediate, and high-risk groups were 85.5%, 56.6%, and 15.6%, respectively (p < 0.001) in the development cohort, and 87.5%, 58.5%, and 25.0%, respectively (p < 0.001) in the validation cohort.Conclusion A preoperative risk scoring system that incorporates clinical and CT imaging features was valuable in identifying high-risk patients with ICCA for ER following resection. KCI Citation Count: 0 |
| Author | Park, Mi-Suk Rhee, Hyungjin Lee, Seung Soo Kim, Sehee Choi, Sang Hyun Yeom, Suk-Keu Kim, Dong Hwan Cho, Eun-Suk Park, Sumi |
| Author_xml | – sequence: 1 givenname: Dong Hwan orcidid: 0000-0002-2932-2367 surname: Kim fullname: Kim, Dong Hwan – sequence: 2 givenname: Sang Hyun orcidid: 0000-0002-6898-6617 surname: Choi fullname: Choi, Sang Hyun – sequence: 3 givenname: Sehee surname: Kim fullname: Kim, Sehee – sequence: 4 givenname: Hyungjin surname: Rhee fullname: Rhee, Hyungjin – sequence: 5 givenname: Eun-Suk surname: Cho fullname: Cho, Eun-Suk – sequence: 6 givenname: Suk-Keu surname: Yeom fullname: Yeom, Suk-Keu – sequence: 7 givenname: Sumi surname: Park fullname: Park, Sumi – sequence: 8 givenname: Seung Soo surname: Lee fullname: Lee, Seung Soo – sequence: 9 givenname: Mi-Suk surname: Park fullname: Park, Mi-Suk |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39930855$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003254043$$DAccess content in National Research Foundation of Korea (NRF) |
| BookMark | eNqFkcFu1DAQhi1URLeFI1fkI0LKEjuOk3CrlgVWKgK1has1ccZbU8dOnaSwj8Lb4t0tXJEsjSx9_z_SfGfkxAePhLxk-VIwUbzVcVrynIslY3X1hCx4npdZw0t5QhasbOqMN019Ss7G8UeeS1FU7Bk5LZqmyOuyXJDfXyOGASNM9gFp-nRWTzZ4-jl06KgJka4huh29Qj3HiF4jDYZu_BThFocU03R1Gxz4rQ0aorY-9EDBTBjp9Ry3VoNL4REPte_oe3xAF4Ye_UTBd3T9K5E-Md_B2Q4Ou6-nuds9J08NuBFfPM5z8u3D-mb1Kbv88nGzurjMNBd5lUHDO1Y3JRpTGaMlb7UwFaBBxjtZt0zUwvCyZQ12soJWYGF0JfePtbJoi3Py5tjro1F32qoA9jC3Qd1FdXF1s1Esr6QshEzw8gjPfoDdT3BODdH2EHeJUXshKglReyFqLyQFXh8DQwz3M46T6u2o0aWDYZhHVTBZClbyQ_erR3Rue-z-Ff-VlYDsCOgYxjGi-c_uPzB1qSw |
| Cites_doi | 10.1159/000513704 10.1002/jhbp.543 10.3389/fonc.2018.00360 10.1002/bjs.10676 10.1016/j.jamcollsurg.2016.05.019 10.1245/s10434-023-13636-8 10.1001/jamasurg.2020.1973 10.1001/jamasurg.2013.5137 10.1007/s00259-023-06184-6 10.1245/s10434-022-11463-x 10.1038/s41575-020-0310-z 10.1016/j.jhep.2023.03.010 10.1093/annonc/mdy282.146 10.1016/j.jhep.2019.03.013 10.1245/s10434-020-09536-w 10.3389/fonc.2022.896764 10.1001/jamasurg.2013.5168 10.21037/cco.2018.07.03 10.21037/hbsn.2018.03.16 10.1111/liv.15196 10.1186/s40644-019-0234-4 10.1016/j.ejrad.2023.110839 10.3322/caac.21759 10.1002/jso.24720 10.1245/s10434-020-09393-7 10.1200/jco.2022.40.16_suppl.4097 10.1038/s41598-022-12604-8 10.3322/caac.21820 10.1093/annonc/mdq650 10.1002/jso.24381 |
| ContentType | Journal Article |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 ADTOC UNPAY ACYCR |
| DOI | 10.4143/crt.2024.1187 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Unpaywall for CDI: Periodical Content Unpaywall Korean Citation Index |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE CrossRef |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2005-9256 |
| EndPage | 1166 |
| ExternalDocumentID | oai_kci_go_kr_ARTI_10766346 10.4143/crt.2024.1187 39930855 10_4143_crt_2024_1187 |
| Genre | Validation Study Multicenter Study Journal Article |
| GroupedDBID | --- 29B 5-W 53G 8JR 9ZL AAYXX ABDBF ACUHS ACYCR ADBBV AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION DIK E3Z EBD EF. F5P HYE OK1 RPM TR2 C1A CGR CUY CVF ECM EIF NPM 7X8 ADTOC UNPAY |
| ID | FETCH-LOGICAL-c2407-a92d1895eff7ffc62bc4f7aefe12d68b1484f25b19ed67ab4e3fc76c76c1b63b3 |
| IEDL.DBID | UNPAY |
| ISSN | 1598-2998 2005-9256 |
| IngestDate | Thu Oct 16 03:18:03 EDT 2025 Sun Oct 26 03:58:18 EDT 2025 Thu Oct 02 06:31:26 EDT 2025 Sun Oct 19 00:28:50 EDT 2025 Sat Oct 25 05:22:08 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | Recurrence Liver Cholangiocarcinoma Multidetector computed tomography |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c2407-a92d1895eff7ffc62bc4f7aefe12d68b1484f25b19ed67ab4e3fc76c76c1b63b3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-2932-2367 0000-0002-6898-6617 |
| OpenAccessLink | https://proxy.k.utb.cz/login?url=https://doi.org/10.4143/crt.2024.1187 |
| PMID | 39930855 |
| PQID | 3165415246 |
| PQPubID | 23479 |
| PageCount | 11 |
| ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_10766346 unpaywall_primary_10_4143_crt_2024_1187 proquest_miscellaneous_3165415246 pubmed_primary_39930855 crossref_primary_10_4143_crt_2024_1187 |
| PublicationCentury | 2000 |
| PublicationDate | 2025-10-01 |
| PublicationDateYYYYMMDD | 2025-10-01 |
| PublicationDate_xml | – month: 10 year: 2025 text: 2025-10-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Korea (South) |
| PublicationPlace_xml | – name: Korea (South) |
| PublicationTitle | Cancer research and treatment |
| PublicationTitleAlternate | Cancer Res Treat |
| PublicationYear | 2025 |
| Publisher | 대한암학회 |
| Publisher_xml | – name: 대한암학회 |
| References | ref13 ref12 ref15 ref14 ref31 ref30 Endo (ref4) 2008 ref11 ref33 ref10 ref2 ref1 ref17 ref16 ref19 ref18 Camp (ref24) 2004 Primrose (ref32) 2019 ref23 ref26 ref25 ref20 ref22 ref21 ref28 ref27 ref29 ref8 ref7 ref9 ref3 ref6 ref5 |
| References_xml | – start-page: 7252 volume-title: X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization year: 2004 ident: ref24 – ident: ref28 doi: 10.1159/000513704 – ident: ref8 doi: 10.1002/jhbp.543 – ident: ref18 doi: 10.3389/fonc.2018.00360 – ident: ref10 doi: 10.1002/bjs.10676 – ident: ref21 doi: 10.1016/j.jamcollsurg.2016.05.019 – ident: ref23 doi: 10.1245/s10434-023-13636-8 – ident: ref11 doi: 10.1001/jamasurg.2020.1973 – ident: ref6 doi: 10.1001/jamasurg.2013.5137 – ident: ref33 doi: 10.1007/s00259-023-06184-6 – ident: ref22 doi: 10.1245/s10434-022-11463-x – ident: ref30 doi: 10.1038/s41575-020-0310-z – ident: ref31 doi: 10.1016/j.jhep.2023.03.010 – start-page: 663 volume-title: Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study year: 2019 ident: ref32 – ident: ref12 doi: 10.1093/annonc/mdy282.146 – ident: ref2 doi: 10.1016/j.jhep.2019.03.013 – ident: ref13 doi: 10.1245/s10434-020-09536-w – ident: ref16 doi: 10.3389/fonc.2022.896764 – ident: ref26 doi: 10.1001/jamasurg.2013.5168 – ident: ref20 doi: 10.21037/cco.2018.07.03 – ident: ref3 doi: 10.21037/hbsn.2018.03.16 – ident: ref19 doi: 10.1111/liv.15196 – ident: ref17 doi: 10.1186/s40644-019-0234-4 – ident: ref29 doi: 10.1016/j.ejrad.2023.110839 – ident: ref5 doi: 10.3322/caac.21759 – ident: ref7 doi: 10.1002/jso.24720 – ident: ref9 doi: 10.1245/s10434-020-09393-7 – ident: ref14 doi: 10.1200/jco.2022.40.16_suppl.4097 – ident: ref15 doi: 10.1038/s41598-022-12604-8 – ident: ref1 doi: 10.3322/caac.21820 – start-page: 84 volume-title: Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection year: 2008 ident: ref4 – ident: ref27 doi: 10.1093/annonc/mdq650 – ident: ref25 doi: 10.1002/jso.24381 |
| SSID | ssj0064371 |
| Score | 2.355337 |
| Snippet | Purpose We aimed to develop a preoperative risk scoring system to predict early recurrence (ER) of intrahepatic cholangiocarcinoma (ICCA) after resection,... We aimed to develop a preoperative risk scoring system to predict early recurrence (ER) of intrahepatic cholangiocarcinoma (ICCA) after resection, utilizing... |
| SourceID | nrf unpaywall proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database |
| StartPage | 1156 |
| SubjectTerms | Aged Bile Duct Neoplasms - pathology Bile Duct Neoplasms - surgery Cholangiocarcinoma - diagnostic imaging Cholangiocarcinoma - mortality Cholangiocarcinoma - pathology Cholangiocarcinoma - surgery Female Humans Male Middle Aged Neoplasm Recurrence, Local - pathology Neoplasm Staging Preoperative Period Prognosis Risk Assessment Risk Factors Tomography, X-Ray Computed 의학일반 |
| Title | Preoperative Prediction Model for Early Recurrence of Intrahepatic Cholangiocarcinoma after Surgical Resection: Development and External Validation Study |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/39930855 https://www.proquest.com/docview/3165415246 https://doi.org/10.4143/crt.2024.1187 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003254043 |
| UnpaywallVersion | publishedVersion |
| Volume | 57 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | Cancer Research and Treatment, 2025, 57(4), , pp.1156-1166 |
| journalDatabaseRights | – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 2005-9256 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0064371 issn: 1598-2998 databaseCode: ABDBF dateStart: 20120301 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 2005-9256 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0064371 issn: 1598-2998 databaseCode: DIK dateStart: 20040101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVERR databaseName: KoreaMed Open Access customDbUrl: eissn: 2005-9256 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0064371 issn: 1598-2998 databaseCode: 5-W dateStart: 20010101 isFulltext: true titleUrlDefault: https://koreamed.org/journals providerName: Korean Association of Medical Journal Editors – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 2005-9256 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0064371 issn: 1598-2998 databaseCode: RPM dateStart: 20040101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1tb9MwED6xVgL2gfeX8jIZgeBTCkltp-FbN1ZtSJsmoGh8smzHHlVLUmWNpu2f8G-5c9KpvAiQIkWRbMexz7k7-7nnAF6gXyxsLrIotkMZcTkw0ZBbGRmbpW-8oaMb2u84OJR7E_7-WBy3IBqKhVk7v-eoyl_bigCPCe9TWuwN6EqBJncHupPDo9GXwIWaURRByHkbWDUz1OENl-bv9X_SPRtF5f9kVm7CtbpY6PMzPZ-vqZrxTRivOtkgTGb9emn69uIX_sZ_fsUtuNEam2zUSMdtuOKKO3D1oD1OvwvfjypXLlxD_s3wIZ-GMAdGGdLmDO1ZFgiQ2QfalQ9xgaz0bJ82hL86wmJbtkPOcXEyRZ1YYavlN81GlHecfayr8FdlBO4Lzb5laxAlpouc7bYc1OwzugNNdidGyMbzezAZ737a2YvaXA2RJZ8w0lmSx8NMOO9T761MjOU-1c67OMnl0KDXxX0iTJy5XKbacDfwNpV0xQYlZHAfOkVZuIfA8B9shJMZ99Zy6YTWzmhvYpPELhcu6cHL1SyqRUPJodCVoYFWONCKBlrRQPfgOc6xmtmpIhJtup-UalYpdBX2sUqK1haXPXi2kgGFS4vOS3ThyvpUDSjSC-0bKvOgEY7LF5JdRxC_Hry6lJa_9-bRf5d8DNcTyjIcIINPoLOsavcUTZ-l2YLuaPvd9nirXQA_AM2EAX4 |
| linkProvider | Unpaywall |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1tb9MwED6xToLxgfdBedMhEHxKIanjNHyrplUb0qYJKBqfLNuxR9WSVKERGv-Ef8udk07lRYAUKYpkO4598d3Zzz0H8Iz84tQWaR7FdiQjIYcmGgkrI2Pz7JU3fHTD-x1Hx_JgKt6cpqcdiIZjYTbO7wWp8pe2ZsBjIgacFnsLtmVKJncPtqfHJ-OPgQs15yiCkPM2sGrmpMNbLs3f6_-ke7bK2v_JrLwKV5pyqc-_6sViQ9VMrsNk3ckWYTIfNCszsN9-4W_851fcgGudsYnjVjpuwiVX3oLLR91x-m34flK7aula8m-kh2IWwhyQM6QtkOxZDATI-JZ35UNcIFYeD3lD-JNjLLbFPXaOy7MZ6cSaWq0-axxz3nF819RhVUUG94VmX-MGRAl1WeB-x0GNH8gdaLM7ISMbz-_AdLL_fu8g6nI1RJZ9wkjnSRGP8tR5n3lvZWKs8Jl23sVJIUeGvC7hk9TEuStkpo1wQ28zyVdsSEKGu9Arq9LdA6Q12KRO5sJbK6RLtXZGexObJHZF6pI-PF_Polq2lByKXBkeaEUDrXigFQ90H57SHKu5nSkm0eb7WaXmtSJX4ZCqZGRtCdmHJ2sZUPRr8XmJLl3VfFFDjvQi-4bL3G2F4-KFbNcxxK8PLy6k5e-9uf_fJR_ATsJZhgNk8CH0VnXjHpHpszKPO8H_AcojAAw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Preoperative+Prediction+Model+for+Early+Recurrence+of+Intrahepatic+Cholangiocarcinoma+after+Surgical+Resection%3A+Development+and+External+Validation+Study&rft.jtitle=Cancer+research+and+treatment&rft.au=%EA%B9%80%EB%8F%99%ED%99%98&rft.au=%EC%B5%9C%EC%83%81%ED%98%84&rft.au=%EA%B9%80%EC%84%B8%ED%9D%AC&rft.au=%EC%9D%B4%ED%98%95%EC%A7%84&rft.date=2025-10-01&rft.pub=%EB%8C%80%ED%95%9C%EC%95%94%ED%95%99%ED%9A%8C&rft.issn=1598-2998&rft.eissn=2005-9256&rft.spage=1156&rft.epage=1166&rft_id=info:doi/10.4143%2Fcrt.2024.1187&rft.externalDBID=n%2Fa&rft.externalDocID=oai_kci_go_kr_ARTI_10766346 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1598-2998&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1598-2998&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1598-2998&client=summon |